LJM 1993-2820 1819-6357 Libyan Journal of Medicine, Vol. 6, No. 0, January 2011, pp. 1–8 sici xxx PUBMED Abbreviation Maicon Roberto Kviecinski Karina Bettega Felipe João Francisco Gomes Correia Eduardo Antonio Ferreira Maria Helena Rossi Fernando de Moura Gatti Danilo Wilhelm Filho Rozangela Curi Pedrosa

*Rozangela Curi Pedrosa, Laboratório de Bioquímica Experimental – LABIOEX, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina – CEP: 88040-900, Florianópolis, SC, Brazil, Tel: +55 483721 5048, Fax: +55 483721 9672

Departamento de Bioquímica Universidade Federal de Santa Catarina

Florianópolis Brazil

Centro de Sanidade Animal Instituto Biológico

São Paulo Brazil

Departamento de Ecologia e Zoologia Universidade Federal de Santa Catarina

Florianópolis Brazil

Libyan Journal of Medicine Research Article &agr;Scavenging of free radicals and hepatoprotection by B. pilosa Bidens pilosa is a plant used by Amazonian and Asian folks for some hepatopathies. The hydroethanol crude extract and three fractions were assessed for antioxidant and hepatoprotective effects. Higher levels of scavenger activity on the 1,1-diphenyl-2-picrylhydrazyl radical, inhibition of deoxyribose oxidation and lipid peroxidation in vitro were detected for the ethyl acetate fraction (IC₅₀∼4.3–32.3 µg/ml) followed by the crude extract (IC₅₀∼14.2–98.0 µg/ml). The ethyl acetate fraction, again followed by the crude extract, showed high contents of total soluble polyphenols (3.6±0.2 and 2.1±0.2 GAE/mg, respectively) and presence of a quercetin-derived flavonoid identified as quercetin 3,3′-dimethyl ether 7-O-&bgr;-d-glycopyranoside. Both products were assayed for hepatoprotector effects against CCl₄-induced liver injury in mice. Markers of oxidative stress and hepatic injury were evaluated. The results showed that the 10-day pretreatments (15 mg/kg, p.o.) protected the livers against injury by blocking CCl₄-induced lipid peroxidation and protein carbonylation and the DNA fragmentation was decreased (∼60%). The pretreatments avoided the loss of the plasma ferric reducing/antioxidant power and the elevation of serum transaminases and lactate dehydrogenase activities. The results suggest that the main constituents responsible for the hepatoprotective effects with free radical scavenger power associated are well extracted by performing fractionation with ethyl acetate. The findings support the Brazilian traditional use of this plant and justify further evaluations for the therapeutic efficacy and safety of the constituents of the ethyl acetate fraction to treat some liver diseases. Bidens pilosa L. hydroethanol maceration ethyl acetate fractionation free radical scavenger hepatoprotection CCl⁴ toxicity Free radicals may be causative factors in the etiology of some hepatopathies 1 2. The oxidative stress can be induced by a variety of factors such as exposure to xenobiotics and including carbon tetrachloride (CCl₄). The CCl₄ has been used to study liver damage induced by free radicals in mice because the hepatic injury caused by this compound is quite analogous to its hepatotoxicity in humans 3. In this sense, the free radical scavenger activity and the protective effects of several plants rich in antioxidants against CCl₄ hepatotoxicity have been reported 4 5. Bidens pilosa Linné (Asteraceae) is a medicinal plant with a wide occurrence in the tropical regions and has a history of use by Amazonian Indians and Eastern medicine for several purposes including the treatment of liver diseases, malaria, and tumors 6 7 8 . Previous studies have revealed a broad phytochemical constitution with little peculiarities according to the place where the plant is found. The major compounds already isolated from the plant are flavonoids and polyacetylenes 9. Some promising results were already found when some isolated flavonoids were obtained from the Chinese B. pilosa and assayed as a pool of total flavonoids for hepatoprotective effects 6. Here, the effects of B. pilosa cultivated in South America (Brazil) are examined. A crude hydroethanol extract was obtained and fractionated to yield three other fractions. The plant products were submitted to phytochemical evaluations monitored by assays in vitro and in vivo focusing on free radical scavenger power and hepatoprotective effects. Bidens pilosa L. (Asteraceae) was collected at the Jureia Botanical Reserve (Atlantic Forest), São Paulo state, Brazil. The plant was identified by Inês Cordeiro, and a voucher specimen (M.H. Rossi SP384167) was deposited at the Herbário do Estado Eneida P.K. Fidalgo of the Botanical Institute, São Paulo, Brazil. This study followed the international, Brazilian, and institutional rules concerning the biodiversity rights. The dried aerial parts of the plant were powdered and exhaustively macerated with ethanol-water solution (9:1) at room temperature for 3 days (three times). The solvent was eliminated under low pressure to obtain a dried hydroethanol crude extract (HCE), yielding 8.3% (w/w) in terms of starting material. After, by performing fast column silica gel 60 chromatography with vacuum and applying solvents in increasing polarity order, three fractions were obtained from the HCE. They were named chloroform fraction (f-CHCl₃), ethyl acetate fraction (f-EtOAc), and methanol fraction (f-MeOH) according to the respective solvent used. The fractionation with chloroform yielded 24.9%, while the fractionation with ethyl acetate yielded almost 36% and the methanolic one about 40% (w/w) in terms of the initial HCE. The phytoproducts were kept at room temperature in a dryer device protected against the light. The total polyphenol content (TPC) was determined in each plant sample according to the Folin-Ciocalteu method 10. The reaction mixture was composed of 0.1 ml of extracts, 7.9 ml of distilled water, 0.5 ml of Folin-Ciocalteu reagent, and 1.5 ml of 20% sodium carbonate. It was mixed and allowed to stand for 2 hours. The absorbance was measured at 765 nm and the results were expressed as gallic acid equivalents per milligram of extract (GAE/mg). The f-EtOAc was submitted to reversed phase high performance liquid chromatography (HPLC; Shimadzu LC 6AD, J.T. Baker ODS C-18 column, 5 µm, 4.6 × 250 mm) using 5% aqueous acetic acid: methanol (65:35) as mobile phase at a flow rate of 1 ml/min and ultraviolet detector (Shimadzu, SPD 6AV). The mobile phase was prepared according to that employed by Felicio et al. 11. The spectra of nuclear magnetic resonance (NMR) were recorded on Brucker AC 200 in DMSO-d₆. The ultraviolet–visible (UV–vis) spectra were obtained in a Techcomp Model UV8500 II in MeOH, with a subsequent addition of the usual reagents: NaOAc, NaOH, AlCl₃, HCl, and H₃BO₃. The characterization was based on spectroscopic analyses and comparison with literature 12. The scavenging activity of B. pilosa (HCE, f-MeOH, f-EtOAc, and f-CHCl₃) was evaluated by using the 2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) radical scavenger method measured at 518 nm 13. The hydroxyl radical (HO^·) was generated by the deoxyribose method, and its reaction with thiobarbituric acid (TBA) was indirectly detected by measuring the chromophore at 532 nm 14. Protection against induced lipid peroxidation (LPO) in vitro was assayed by using the TBA method as described by Chen and Tappel 15. The activities of the phytoproducts were evaluated in the range 0.5 to 500 µg/ml and the results were expressed by the half maximal inhibitory concentration (IC₅₀), which was the concentration (in µg/ml) of phytoproduct required to inhibit the generation rates of radicals or lipid peroxidation by 50%. Silymarin, a mixture of four flavonolignans that possesses a recognized free radical scavenger activity as well as a hepatoprotective effect, was used for the positive control 16. Male Balb-c mice, weighing 20±5 g, were housed under controlled conditions and had free access to laboratory chow and water. Animals were allowed to acclimatize for 5 days prior to the treatments. Animals were fasted for 8 hours before experiments but water was allowed ad libitum. All animal procedures were approved by the Ethics Committee of Universidade Federal de Santa Catarina, in accordance with the Principles of Laboratory Animal Care published by the National Institutes of Health (NIH Publication #86–23, revised 1996, US). Hepatotoxicity was induced in mice by an intraperitoneal administration of a single dose of CCl₄ (0.5 ml/kg) done on the day after following the 10-day pretreatments with HCE and f-EtOAc except in the normal control (NC), which received only the vehicle (4). For the experimental pretreatments, the dose was previously determined in a group of 12 animals allocated in four subgroups that received daily for 10 days HCE or f-EtOAc at 1.5, 15, 150, or 300 mg/kg, respectively. The safety of HCE and f-EtOAc was evaluated by observation of behavioral changes and monitoring of the weight of liver and body. After dose selection, mice were randomly divided into five groups (n=12), pretreated for 10 days, and then challenged according to Table 1. Group 10-day pretreatment Dose Challenge on day 11 Normal control group (NC) Vehicle 0.5 ml None Negative control group (NEG) Vehicle 0.5 ml CCl₄ Positive control group (SIL) Silymarin 15 mg/kg CCl₄ HCE group HCE 15 mg/kg CCl₄ f-EtOAc group f-EtOAc 15 mg/kg CCl₄ Twenty-four hours after CCl₄ administration, blood was collected and the serum was separated for the evaluation of the biochemical markers of hepatic injury. After, the animals were sacrificed and the livers were immediately excised, weighed, and kept on ice for the analysis of biomarkers of oxidative stress and the endpoints of hepatotoxicity measured according to the following. The serum enzymatic activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) were measured spectrophotometrically according to Reitman and Frankel 17 and Bergmeyer and Bernt 18 using a commercial kit (LABTEST, Diagnostica S.A., Minas Gerais, Brazil). Malondialdehyde was used as a lipid peroxidation marker and measured in the livers by its capacity to react with thiobarbituric acid to produce thiobarbituric acid reactive substances (TBARS), a pigment that can be quantified spectrophotometrically 19. Results were expressed as contents of TBARS±standard deviation (SD) (in nmol/mg of protein) using ϵ = 153 mmol/L per cm. Oxidative damage to proteins was quantified as carbonyl protein contents. The method is based on the spectrophotometric detection of the end product of the reaction of 2,4-dinitrophenylhydrazine with carbonyl proteins to form protein hydrazones, and the results were expressed as nmoles of carbonyl group per milligram of protein using ϵ = 22 mmol/L per cm 20. The plasma ferric reducing/antioxidant power (FRAP) was determined in a reaction in which a Fe^3 +/tripyridyltriazine complex is reduced by the plasma to produce a chromophore that is determined spectrophotometrically 21. Reduced glutathione (GSH) was measured by a spectrophotometric method through a reaction in solution done with hepatic extracts plus disodium hydrogen phosphate and 5, 5′-dithiobis-(2-nitrobenzoic acid; DTNB) to form a chromophore read at 412 nm using ϵ = 14.1 mmol/L per cm. Results were expressed in µmol per g of tissue 22. The catalase activity (CAT) was determined by measuring its capacity to decompose hydrogen peroxide in solution under absorbance at 240 nm with time, at 37°C. The results were expressed in mmol/min per g of tissue and ϵ = 40 mmol/L per cm 23. DNA fragmentation was assessed using the comet assay 24. Samples (100 mg) of liver tissue were homogenized in 1 ml of phosphate-buffered saline (PBS; 1:9) and 10 µl of this solution was added to 70 µl of 0.75% low-melting point agarose. The cell/agarose mixture was added to a fully frosted microscope slide coated with a layer of 300 µl of normal-melting agarose (1%). The slides were immersed in a cold and freshly made lysis solution (2.5 mM NaCl, 100 mM ethylenediamine tetraacetic acid [EDTA], 1% Triton X-100, 10% dimethyl sulfoxide [DMSO], and 10 mM Tris, pH 10) for a minimum of 2 hours. Subsequently, the slides were incubated in freshly prepared alkaline buffer (300 mM NaOH and 1.0 mM EDTA, pH 13) for 30 minutes. The DNA was subjected to electrophoresis for 30 minutes at 280 mA and 25 V and then neutralized with 0.4 M Tris, pH 7.5. Finally, DNA was stained with ethidium bromide (2.0 µg/ml). Images of 100 randomly selected comets (50 from each of two replicate slides) were analyzed from each animal and their lengths (nuclear region + tail) were measured in arbitrary units. A DNA damage index (DI) was compiled according to tail size, from undamaged (0) to maximally damaged (400), resulting in a single DNA damage score for each animal and, consequently, for each group studied. Thus, the DI of each group ranged from 0 (completely undamaged) to 400 (maximum damage). All the biochemical parameters were measured in triplicate. Data were expressed as mean±SD. Comparisons and differences were denoted by means of Student's t-test and/or the ANOVA test complemented by the Tukey-Kramer multiple comparison test. The P<0.05 was regarded as significant. Bidens pilosa L. has a long history of use by Amazon Indigenous and Asian medicine as hepatoprotector. All parts of the plant are used in the medicinal preparations, which are mainly water–alcohol macerations in bottles or herbal teas used orally or topically 25. It is a constituent of some liver elixirs commercially available in some countries. The HCE was prepared and evaluated here in an attempt to correspond to the popular use of the plant. Additionally, HCE was fractionated to yield three other products technically obtained. Then their antioxidant potential and hepatoprotective effects were evaluated. Data depicted in Table 2 demonstrate that HCE and its three fractions presented a content of total polyphenolics. The results indicated that f-EtOAc followed by HCE have high contents of such compounds (Table 2). Further evaluations on f-EtOAc were done through HPLC and the chemical characterization was based on spectroscopic methods. Three major peaks were obtained after retention times of 3.10, 3.35, and 3.78 min at 258 nm. The majority of constituents of f-EtOAc (t _R=3.10 min) were isolated by chromatography on a preparative scale and then submitted to spectroscopic analyses (¹H and ¹³C NMR, UV–vis, and thin layer chromatography analysis). Spectral data obtained for this compound corresponded to those obtained for the flavonoid quercetin 3,3′-dimethyl ether 7-O-&bgr;-D-glycopyranoside described in the literature 12. These data are according with the strong antioxidant activity shown by f-EtOAc (Table 2 and Table 3). Sample DPPH IC₅₀ (µg/ml) OH IC₅₀ (µg/ml) LPO IC₅₀ (µg/ml) TPC (GAE/mg) Note: Hydroethanol crude extract (HCE), ethyl acetate fraction (f-EtOAc), methanol fraction (f-MeOH), and chloroform fraction (f-CHCl₃). Values are expressed as means±SD (n=3). IC₅₀: half maximal inhibitory concentration was obtained by linear regression. ^aDenotes significant differences at P < 0.05 in comparison to the positive control (SIL). ^bIn comparison to HCE, f-MeOH, or f-CHCl₃. HCE 98.0±1.0^a 14.2±3.2^a 35.8±3.9^a 2.1±0.2 f-EtOAc 32.3±6.7^a 4.3±1.5 25.1±4.5 3.6±0.2^b f-MeOH 102.9±2.4^a 18.5±8.2^a 90.4±3.4^a 1.0±0.1 f-CHCl₃ 248.0±1.8^a 33.0±6.0^a 166.3±2.6^a 0.8±0.1 Silymarin 13.9±0.7 7.6±0.8 10.1±4.5 – Biomarkers of oxidative damage and antioxidant defenses Group FRAP (mM) GSH (µmol/g) CAT (mmol/min.g) Note: Values are expressed as means ± SD (n=6). ^aDenotes significant statistic differences at P < 0.05 in comparison to the negative control group (NEG). ^bIn comparison to the normal control group (NC). NC 21.7±0.7^a 34.1±3.1^a 163.7±29.6^a NEG 11.7±0.8 8.1±3.6 517.6±67.9 f-EtOAc 20.7±0.7^a 30.1±0.4^a 366.4±44.9^a,b HCE 18.9±0.9^a 25.8±1.5^a,b 447.1±33.1^b Silymarin 24.5±2.0^a 29.8±4.2^a 441.6±44.3^b The in vitro scavenging activity of the plant samples was first discerned by the DPPH radical assay, which primarily evaluates proton radical-scavenging ability. There were differences in terms of scavenging capacity on the DPPH radicals between the least effective fraction (f-CHCl₃) and the most effective one (f-EtOAc), which presented activity comparable to that of Silymarin (Table 2). The HCE and the fractions were evaluated for their ability to inhibit hydroxyl radical generation using a deoxyribose reaction system. Other earlier studies that used this system to assess the effects of natural products reported that molecules able to inhibit the deoxyribose degradation are those that can chelate iron ions and render them poorly active in the Fenton reaction 26. The results showed that all the samples and Silymarin exhibited inhibitory activity against hydroxyl radical generation in vitro. Again, f-EtOAc and HCE were the most effective samples. With stronger action, f-EtOAc presented lower IC₅₀ (Table 2). The results demonstrate that some derivatives from B. pilosa were effective at protecting the rat liver homogenates against induced lipid peroxidation (LPO) in vitro. Most plant products assayed here showed a high lipid peroxidation inhibitory activity in a concentration-dependent manner in vitro, displaying IC₅₀ <100 µg/ml and again f-EtOAc exhibited the strongest activity among the examined samples. The higher contents of polyphenols in f-EtOAc were apparently associated with the higher antioxidant capacities in vitro (Table 2). Previous studies have already demonstrated that the ethyl acetate fractions and the butanolic ones particularly, partitioned from the total crude extract of Chinese B. pilosa, could exhibit significant antioxidant activity in vitro (IC₅₀ 14–17 µg/ml), comparable to that of &agr;-tocopherol 27. Here, although sometimes superior, IC₅₀s were found for the Brazilian samples, data of f-EtOAc (IC₅₀ 4.3–32.3 µg/ml) confirmed its expressive activity when compared to our positive control Silymarin (Table 2). Silymarin is an extract from Silybum marianum used in clinical practice in some countries for the treatment of toxic liver diseases. Its major active constituent is Silibinin, an antihepatotoxic flavolignan 28. Silymarin presented IC₅₀ 7.6–13.9 µg/ml in the assays of the antioxidant power in vitro. It is interesting to note that data of f-EtOAc and HCE, related to the most important in vitro antioxidant activities, were associated with the higher contents of polyphenolics. As a consequence of these preliminary results, in the following, the activities in vivo were determined only employing these two samples. The CCl₄ hepatotoxicity depends on the reductive dehalogenation of CCl₄ catalyzed by cytochrome P 450 in the hepatocyte leading to the generation of trichloromethyl peroxy radicals, an unstable complex reported to be highly reactive. These radicals attack the membrane lipids causing their peroxidation, and may bind covalently to lipids and proteins causing damage to DNA and triggering processes leading to cell damage 3. Fig. 1 shows some data about the toxicity of CCl₄. In the animals from the negative control, the levels of hepatic lipid peroxidation and carbonyl proteins were strongly increased. Data indicated that pretreatment with f-EtOAc and HCE is effective in preventing the increment of both lipid peroxidation and protein carbonylation levels in livers. Pretreatments with the B. pilosa products led normalization of the levels of these injury markers when compared to the normal control. Accordingly, the activities of f-EtOAc and HCE at 15 mg/kg were considered comparable to that of Silymarin (Fig. 1A/B). This dose was determined by previous observations for behavioral changes after oral administration of a range of doses of HCE or f-EtOAc repeatedly for 10 days. As we had observed in vitro a tendency for dose-dependent effects, the best dose in our case should reach maximal protective effects and, thus, in principle the dose should be the highest one that does not cause apparent toxicity. We found that none of the mice exhibited any abnormal behavioral responses at doses of 1.5 or 15 mg/kg, but mice that received 150 mg/kg or above showed slight toxic symptoms. These included inactiveness, loss of appetite, slow movement, dizziness, and erection of hairs. The administration of repeated daily doses of 15 mg/kg for 10 days did not influence the weight of the body or livers of the mice.

CCl₄ led to increased levels of hepatic lipid peroxidation in treated mice from the negative control group (NEG) compared to the normal control group (NC). The ethyl acetate fraction (f-EtOAC), hydroethanol crude extract (HCE), and the positive control Silymarin (SIL) protected livers from pretreated mice against lipid peroxidation (A); animals from the negative control group (NEG) treated by CCl₄ presented increased levels of carbonyl proteins compared to the normal control group (NC). The f-EtOAC, HCE, and the positive control Silymarin (SIL) protected livers from pretreated mice against oxidative damage to proteins (B). All values are expressed as means±SD, n=6. ^aDenotes significant statistic difference compared to NEG (P<0.05).

Sometimes a direct association between the antioxidant activity and the reducing power of certain plant extracts can be found. The reducing properties are generally associated with the presence of reducing agents, which have been shown to exert an antioxidant action by breaking the free radical chain by donating hydrogen atoms 29. Data in Table 3 demonstrate that plasma FRAP was found decreased in response to CCl₄ in animals from the negative control. Once again, the data show that f-EtOAc and HCE prevented the CCl₄ toxic effects. The f-EtOAc caused total recovery in terms of the plasma FRAP to levels comparable to that of the normal control. The HCE was a little less active, while Silymarin exhibited the best activity in this respect (Table 3). Pretreatment with f-EtOAc, HCE, or Silymarin (15 mg/kg, 10 days) was effective in avoiding the GSH depletion induced by CCl₄. The GSH levels in livers recovered in more than 85% when the pretreatments were done with f-EtOAc or Silymarin. Pretreatment with HCE caused about 75% recovery of GSH when compared to the negative control (Table 3). The CCl₄ led to increased CAT activity in livers of challenged mice. Only f-EtOAc was little effective in avoiding the elevation of CAT activity (Table 3). The results show a significant increase in the activities of serum AST, ALT, and LDH thus confirming the hepatocellular damage in mice challenged by CCl₄ (Table 4). After pretreatment with f-EtOAc or HCE, the activities of these enzymes decreased. Animals pretreated with f-EtOAc presented activities of transaminases and LDH closer to those of the normal group (Table 4). The favorable results of HCE and especially f-EtOAc from B. pilosa were confirmed by their prevention of DNA fragmentation induced by CCl₄ in hepatocytes of mice (Fig. 2). Fluorescence microscopy revealed a reduction (∼30%) in terms of DNA fragmentation in samples of hepatic tissue from animals pretreated with Silymarin, and a near 50% reduction in samples from animals pretreated with HCE, when compared to the negative control group (NEG). Pretreatment with f-EtOAC was able to cause a decrease of around 60% in terms of DNA fragmentation when compared to the negative control group (Fig. 2).

DNA damage index (0–400) in hepatocytes from mice from the normal control group (NC), negative control group (NEG), positive control group pretreated with Silymarin at 15 mg/kg, p.o. (SIL), and from mice pretreated with the extracts from Bidens pilosa, the hydroethanol crude extract (HCE) or fraction ethyl acetate (f-EtOAc) both at 15 mg/kg (p.o) and on the 11th day treated with CCl₄ (0.5 ml/kg, i.pl). All values are expressed as means ± SD, n=6. ^aDenotes significant difference compared to NEG (P<0.05).

Serum enzymes Group AST (U/L) ALT (U/L) LDH (U/L) ^aDenotes significant statistic differences at P < 0.05 in comparison to the negative control group (NEG). ^bIn comparison to the normal control group (NC). Note: Values are expressed as means±SD (n=6). Abbreviations: Alanine aminotransferase (ALT); aspartate aminotransferase (AST); lactate dehydrogenase (LDH). NC 9.1±1.1^a 29.2±3.5^a 237.2±38.3^a NEG 68.4±1.6 91.0±1.5 541.4±41.2 f-EtOAc 12.3±1.4^a 33±10^a 272.4±33.7^a HCE 21.3±0.9^a,b 48.0±2.1^a,b 295.1±29.3^a Silymarin 24.4±1.4^a,b 53.0±2.5^a,b 289.6±30.5^a Although rather speculative, the in vivo findings might be due to the free radical scavenging properties of the polyphenol constituents and flavonoids of B. pilosa, but other mechanisms might also be involved. Oxidative stress is consistently present in liver intoxications 30. The present study provides important information on the therapeutic virtues of these plant products, which are apparently well in line with its properties as reported by traditional medicine. Recently, a study by Yuan et al. 8 reported that a 10-day pretreatment with a brown powder (50 and 100 mg/kg) extracted from samples of B. pilosa purchased at a crude drug market (China) reduced the CCl₄-induced elevated liver index (liver weight/body weight), serum ALT and AST levels, and hepatic malonyl dialdehyde content and restored hepatic superoxide dismutase and glutathione peroxidase activities in acute liver injury in mice. Actually, the powder was a kind of a pool of purified flavonoids and glucosides in which they identified hyperoside, rutin, maritimetin, quercetin, okanin, iso-okanin, 7-O-(4,6-diacetyl)-d-glucopyranoside, (Z)-6-O-(3,6-di-O-acetyl-d-glucopyranosyl)-6,7,3,4-tetrahydroxyaurone, and 2,4,6-trimethoxy-4-O-dglucopyranosyl-dihydrochalcone. Interestingly, data obtained by administering the Brazilian samples under the same 10-day scheme of pretreatment is corroborative and comparable even considering that this work detected activity in pretreatments done with the HCE and especially f-EtOAc. Again, it is noteworthy that we did not observe apparent toxicity for HCE or f-EtOAc at the mentioned doses (1.5 or 15 mg/kg). Additionally, data obtained here indicate advantages in terms of bioactivity by applying fractionation with ethyl acetate. Some protective effects of some constituents of B. pilosa are reaffirmed here besides their free radical scavenging power. We recognized the value of some specific constituents of the plant, mainly quercetin-derived flavonoids. From the overall results, we conclude that some constituents of B. pilosa do possess free radical scavenging activity, which exert a beneficial action in preventing liver damage induced by CCl₄. Since the preliminary analyses of the samples showed the presence of polyphenols by identifying quercetin-derived glycosylated flavonoids in the ethyl acetate fraction, the antioxidant and hepatoprotective activities of substances like these are known and, therefore, we speculate that these constituents might be the main components responsible for the observed effects. The results support the popular use of the plant as hydroethanol solutions, although the derived products enriched in flavonoids were even more effective in preclinical evaluations. These findings justify further evaluations of the efficacy and safety of the liver elixirs made with B. pilosa L. enriched in flavonoids. The authors have not received any funding or benefits from industry or elsewhere to conduct this study. R.C. Pedrosa (Proc. 300718/2003-9) and D. Wilhelm Filho (Proc. 309438/2008-0) are recipients of research grants from the Conselho Nacional de Pesquisa (CNPq-MCT, Brazil) Additionally, the authors are grateful to Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil) for providing financial assistance in the form of research scholarships. Poli G. Liver damage due to free radicals Br Med Bull. 1993 49 604 20 Gülçin I Bursal E Sehitoglu MH Bilsel M Gören AC. Polyphenol contents and antioxidant activity of lyophilized aqueous extract of propolis from Erzurum, Turkey Food Chem Toxicol. 2010 48 2227 38 Recknagel RO Glende EA Dolack JA Walter RL. Mechanism of carbon tetrachloride toxicity Pharmacol Ther. 1992 43 139 54 Carbonari K Ferreira EA Rebello JM Felipe KB Rossi MH Felicio JD Free-radical scavenging by Ouratea parviflora in experimentally-induced liver injuries Redox Report. 2006 11 124 30 Sengottuvelu S , Gopal N. Hepatoprotective activity of Clerodendrum inerme against CCL₄ induced hepatic injury in rats. Fitoterapia. 2008; 79: 24–26. DOI: 10.1016/j.fitote.2007.07.006. Brandão MGL Krettli AU Soares LSR Nery CGC Marinuzzi HC. Antimalarial activity of extracts and fractions from Bidens pilosa and other Bidens species (Asteraceae) correlated with the presence of acetylene and flavonoid compounds J Ethnopharmacol. 1997 57 131 8 Kviecinski MR , Felipe KB , Schoenfelder T , Wiese LPL , Rossi MH , Gonçalvez E , Study of the antitumor potential of Bidens pilosa (Asteraceae) used in Brazilian folk medicine. J Ethnopharmacol. 2008; 117: 69–75. DOI: 10.1016/j.jep.2008.01.017. Yuan LP Chen FH Ling L Dou PF Bo H Zhong MM Protective effects of total flavonoids of Bidens pilosa L. (TFB) on animal liver injury and liver fibrosis J Ethnopharmacol. 2008 116 539 46 Grombone-Guarantini MT , Silva-Brandão KL Solferini VN , Semir J , Trigo JR . Sesquiterpene and polyacetylene profile of the Bidens pilosa complex (Asteraceae: Heliantheae) from Southeast of Brazil. Biochem System Ecol. 2005; 33: 479–86. DOI: 10.1016/j.bse.2004.11.005. Singleton VI Rossi J. Colorimetry of total phenolic with phosphomolybdic-phosphotungstic acid reagents Am J Enol Vitic. 1965 16 144 58 Felicio JD Santos R Gonçalez E. Chemical constituents from Vitis vinifera (Vitaceae) Arq Inst Biol. 2001 68 47 50 Brandão MGL , Nery CGC , Mamão MA , Krettli AU . Two methoxylated flavone glycosides from Bidens pilosa. Phytochemistry. 1998; 48: 397–9. DOI: 10.1016/S0031-9422(97)01113-8. Brand-Williams W , Cuvelier ME , Berset C. Use of free radical method to evaluate antioxidant activity. Lebensm-Wiss Technol. 1995; 28: 25–30. DOI: 10.1016/S0023-6438(95)80008-5. Halliwell B Gutteridge JMC. Formation of thiobarbituric acid-reactive substance from deoxyribose in the presence of iron salts – the role of superoxide and hydroxyl radicals FEBS Lett. 1981 128 347 52 Chen H , Tappel AL . Protection of multiple antioxidants against heme protein oxidation and lipidic peroxidation induced by CBrCl₃ in liver, lung, heart, and spleen. J Agric Food Chem. 1996; 44: 854–8. DOI: 10.1021/jf950562f. Köksal E Gülçin I Beyza S Sarikaya O Bursal E. In vitro antioxidant activity of silymarin J Enzyme Inhib Med Chem. 2009 24 395 405 Reitman S Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamine pyruvic transaminases Am J Clin Pathol. 1957 28 56 63 Bergmeyer HU Bernt E. UV-assay with pyruvate and NADH Methods of enzymatic analysis 2nd ed. Bergmeyer HU Academic Press NY 1974 574 8 Okawa H Ohishi N Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem. 1979 95 351 8 Levine RL Garland D Oliver CN Amici A Climet I Lenz AG Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 1990 186 464 78 Benzie IFF Strain JJ. Ferric reducing antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration Methods Enzymol. 1999 299 15 27 Anderson ME. Determination of glutathione and glutathione disulfide in biological samples Methods Enzymol. 1985 113 548 55 Aebi H. Catalase in vitro Methods Enzymol. 1984 105 121 6 Singh NP McCoy MT Tice RR Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells Exp Cell Res. 1988 175 184 91 Corrêa MP , Dicionário das plantas úteis do Brasil – e das exóticas cultivadas. Brazil : Instituto Brasileiro de desenvolvimento florestal (Ministério da Agricultura); 1984 . Halliwell B Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview Methods Enzymol. 1990 186 1 85 Chiang YM Chuang DY Wang SY Kuo YH Tsai PW Shyur LF. Metabolite profiling and chemopreventive bioactivity of plant extracts from Bidens pilosa J Ethnopharmacol. 2004 95 409 19 Pradhan SC Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine Indian J Med Res. 2006 124 491 504 Cadenas E Sies H. Oxidative stress: excited oxygen species and enzyme activity Adv Enzyme Regul. 1985 23 217 37 Parola M Robino G. Oxidative stress-related molecules and liver fibrosis J Hepatol. 2001 35 297 306